Comparison Of Rocuronium Reversal By Sugammadex To Succinylcholine For Electroconvulsive Therapy (ECT)
Clinical trial NCT03532178 · COMPLETED
Trial details
- NCT number
- NCT03532178
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-01
- Primary completion
- 2022-03-31
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.